Anti-inflammatory effects of daidzein on primary astroglial cell culture

Authors: Liu, Man-Hai1; Lin, Yu-Shan1; Sheu, Shiow-Yunn2; Sun, Jui-Sheng3

Source: Nutritional Neuroscience, Volume 12, Number 3, June 2009 , pp. 123-134(12)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Introduction: Alzheimer's disease is the common cause of dementia in old people. The pathological hallmarks of Alzheimer's disease include neuronal loss, deposition of amyloid-?, and presence of neurofibrillary tangles. The endogenous steroid estrogen has been shown to affect neuronal growth, differentiation and survival, while isoflavones also have a neuroprotective effect on human cortical neurons. Daidzein, however, has a superior neuron-protective effect to other isoflavones. The present study is to determine whether daidzein is able to inhibit the production of pro-inflammatory mediators under amyloid-? and lipopolysaccharide stimulation.

Materials and methods: Astrocyte cells were stimulated with amyloid-? or lipopolysaccharide in the absence and presence of diadzein. Nitric oxide released into the culture media was determined using the Griess reaction, and concentrations of IL-1, IL-6, TNF-? and estrogen receptor gene expression were measured by semi-quantitative real-time polymerase chain reaction assay.

Results: Diadzein-treatment increases astrocyte cell counts and attains its maximal effect at the 10?12M concentration. The addition of 20 ?M amyloid-? or 10?6 g/ml LPS can significantly decrease the viability of astrocytes, up-regulated IL-1, IL-6, TNF-? mRNA and estrogen receptor expression; in addition, 1-h daidzein pre-treatment can restore the decreased viability of astrocytes induced by amyloid-? or lipopolysaccharide as well as down-regulate their mRNA expression.

Conclusions: It seems that this response is estrogen receptor-mediated. These results further increase the possibility that daidzein may have potential to ameliorate the inflammatory process and also alleviate the risk of Alzheimer's disease progression.

Keywords: AMYLOID BETA-PEPTIDE; LIPOPOLYSACCHARIDE; DIADZEIN; NEUROPROTECTIVE EFFECT

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/147683009X423274

Affiliations: 1: Graduate Institute of Pharmacy, Taipei Medical University, Taipei, Taiwan, Republic of China 2: School of Pharmacy, Taipei Medical University, Taipei, Taiwan, Republic of China 3: Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China; Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China

Publication date: 2009-06-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page